SCHEMBL30889666

SCHEMBL30889666

C/C(=C\c1ccccc1)C(=O)c1cccc(C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.50
POLB P06746 4/20 0.47
PARP1 P09874 1/20 0.47
MAPT P10636 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
RAB9A P51151 3/20 0.45
NPC1 O15118 2/20 0.45
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.44
GPR52 Q9Y2T5 1/20 0.43
LMNA P02545 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
AKR1C1 Q04828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11407221 0.84 AKR1C3 (0.67) AKR1C3SMN1; SMN2POLBMAPTMEN1
SCHEMBL6064618 0.84 AKR1C3 (0.67) AKR1C3SMN1; SMN2POLBMAPTMEN1
SCHEMBL351852 0.84 AKR1C3 (0.67) AKR1C3SMN1; SMN2POLBMAPTMEN1
SCHEMBL7701386 0.81 CES2 (0.60) AKR1C3SMN1; SMN2POLBMAPTMEN1
SCHEMBL7701390 0.81 CES2 (0.60) AKR1C3SMN1; SMN2POLBMAPTMEN1
SCHEMBL27323920 0.80 CES2 (0.63) AKR1C3SMN1; SMN2POLBPARP1MAPT
SCHEMBL31529061 0.79 CES2 (0.65) SMN1; SMN2POLBPARP1MAPTMEN1
SCHEMBL3753584 0.79 CES2 (0.65) SMN1; SMN2POLBPARP1MAPTMEN1
SCHEMBL20608267 0.77 AKR1C3 (0.53) AKR1C3SMN1; SMN2POLBPARP1MAPT
SCHEMBL3753879 0.76 PARP1 (0.68) SMN1; SMN2POLBPARP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP disclosed
WO-2024097172-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2024-05-10 WO disclosed